App
Israel Steps Closer to Cannabis Legalization
Israel could become the next country to legalize adult-use cannabis after lawmakers gave preliminary approval to two bills calling for the decriminalization of cannabis and the regulation of its sale for recreational and medical use. Let’s take a closer look at the move and what it means for public companies operating in the country, including […]
Red White & Bloom: Scaling Up through Smart Acquisitions
More than 80 percent of mergers and acquisitions fail to boost shareholder value, according to KPMG, often due to lofty valuations, incompatible cultures, excessive risk, or a combination of these factors. Of course, the cannabis industry has been no exception judging by the $835 million iAnthus/MPX merger and Cresco Labs’ acquisition of Origin House. Companies that manage to beat […]
Mushrooms to Pills: How Psychedelic Drugs Will Come to Market
Psychedelic drugs, such as psilocybin, have a long history of medicinal use. In the 1950s, psychedelics had a short-lived relationship with psychology and psychiatry before a legislative ban in the mid-1960s halted research. The 1990s saw renewed research interest but it wasn’t until the legalization of cannabis that things really took off again. The next […]
Why Extracts Are the Key to Plant-based Medicine
Plants have long been a source of beneficial pharmaceutical compounds, but extraction transformed these plants into the medicines that we know today. With the rapid growth in the cannabis and psychedelic industries, investors may want to keep an eye on extraction companies that have experience in regulated markets. These extracts could pave the way […]
MindMed Completes Dosing 18-MC Phase 1 Study
Company, seeing early success, will advance preparations for Phase 2a clinical trial in opioid addiction See Official Release Here NEW YORK, July 28, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has concluded dosing in a Phase 1 Single Ascending Dose (SAD) study of 18-MC. The dosing of 18-MC was well tolerated […]
Ex-Canopy Growth Geneticist Turns His Focus to Psychedelics
Recently it was announced that ebbu’s Director of Research, Robert Roscow, M.A., would leave a cannabis industry conglomerate to become the Chief Science Officer of the leading psychedelic startup Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE: 0NF). Though the coming and going of executives is commonplace in the corporate world, this latest personnel shakeup has […]
MagicMed Sets Out to Help Partners Develop Pharma-Grade Psychedelics
The psychedelics industry is projected to grow at a 16.3% compound annual growth rate to reach $6.85 billion, according to Data Bridge Market Research, driven by the increasing prevalence of mental health disorders and a growing acceptance of psychedelic drugs for the treatment of these diseases. With more than 15 publicly traded companies, investors have […]
Pure Extracts Seasoned Team Leading The Way In Mushroom Extraction
The initiative to legalize psilocybin, the compound in “magic mushrooms” responsible for the psychedelic effect, is gaining momentum, offering new hope for sufferers of maladies like PTSD, anxiety and addiction, amongst others. On June 30, Oregon Live reported that over 164,000 signatures have been collected, enough to bring legalizing psilocybin in a therapeutic setting […]
3 Ex-U.S. & Canada Cannabis Stocks to Consider for Your Portfolio
The North American cannabis industry has captured all of the headlines, but more than 50 countries around the world have already legalized either medical or adult-use cannabis. In Europe alone, more than 30 countries have some form of legalized cannabis use, from coffee shops in the Netherlands to Germany’s massive medical cannabis market. These international […]
3 Ways to Invest in the Burgeoning CBD Market
The hemp-based cannabidiol, or CBD, market has experienced tremendous growth over the past several years. While growers and extraction businesses experienced much of the early growth, consumer packaged goods and reputable brands are the keys to sustainable growth over the coming years as the market continues to mature. Most high-growth companies are focused on categories […]
Pure Extracts Enters Functional Mushroom Space Backstopped by Expertise in Cannabis Extraction
There are only a few times that investors get an opportunity to get in front of an emerging industry. Think about cannabis or electric vehicles in recent times. There can be tremendous upside, but there is generally a steep learning curve because the markets are so nascent and unique that everything is a […]
Cannabis Demand Remains Healthy Despite COVID-19 Challenges
Oregon cannabis sales topped $100 million for the first time since legalization despite the impact of COVID-19, according to the Oregon Liquor Control Commission. While COVID-19 has impacted nearly every part of the economy, cannabis businesses have remained open as essential businesses in the United States and other parts of the world. Canadian demand is […]
What is the Most Vital Part of an Effective Psychedelic Treatment?
Millions of people have had a psychedelic experience at some point in their life and with new FDA approved medicines and regulatory changes millions more will soon be able to as well. However, without support, it can be challenging to understand and integrate these experiences. Psychedelic substances are not magic bullets, they are only […]
3 Beverage Mega-Trends that Investors Should Watch
Beverages play a key role in almost everyone’s life—from coffee in the morning to an alcoholic drink at dinner or with friends. While the same large companies have dominated the space for years, smaller innovators have experienced the fastest growth rates as they launch high-growth products before getting snapped up by larger competitors. The key […]
DENVER, COLORADO, June 11, 2020 – HempFusion® (“the Company”), a leading dietary supplements company focused on products that contain Hemp/CBD in the United States with distribution of its family of brands to approximately 4,000 retailers across 47 states, is pleased to announce the launch of its Food and Drug Administration (“FDA”) listed Over-the-Counter (“OTC”) Topical Products featuring scientifically documented active ingredients […]
Cannabis for COVID: Israel Pioneers Research into Treatment Options
The COVID-19 crisis has brought the global economy to a grinding halt and impacted nearly every walk of life. With so much hanging in the balance, biotech and pharmaceutical companies around the globe have been rapidly searching for vaccines and treatment options. Researchers in Israel believe that cannabis-derived products could treat patients with COVID-19 and […]
Israel Gives Final Go-Ahead for Cannabis Exports: Here’s Who Could Profit
Israel gave final approval in mid-May for exports of medical cannabis, paving the way for more than one billion shekels ($273 million) in annual revenue. The country will become one of just three countries that have approved the export of medical cannabis to countries that permit its use—after Canada and the Netherlands— when the law […]
Adds Clinical Trial Site at University Hospital Basel and Appoints World Leading Psychedelics Researcher Dr. Matthias Liechti as Principal Investigator View the official release BASEL, Switzerland, June 2, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF) is expanding its Phase 2a clinical trial of LSD microdosing for Adult ADHD. MindMed is the […]
Why CBD-Infused Beverages Could Drive Significant Growth in 2020 & Beyond
The beverage industry is ripe for innovation. Over the past five years, 25 of the top U.S. beverage companies experienced an $18 billion loss in market share as functional beverages, craft beer and spirits and low-calorie drinks have transformed the market. A key driver has been Millennials seeking healthier alternatives to alcohol or lower […]
haveEhave enters lucrative Market Slated to Grow from $34.28 billion in 2018 $185.66 billion by 2026 MIAMI, Fla., June 02, 2020 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today it has signed a letter of intent to acquire 51% of […]
How to Invest in a Global Cannabis Portfolio
North America’s cannabis industry may capture the most headlines, but there are many cannabis frontier markets to keep in mind. In fact, North America represented just 25%, or $86 billion, of the $344 billion global cannabis market in 2018, according to New Frontier Data. Asia, Europe, Africa, Latin America, Oceana and the Caribbean are all […]
Why CBD Infused Beverage Brands Are Ripe for Investment
Coca-Cola purchased Glaceau’s Vitaminwater for more than $4 billion in 2007, making it the beverage giant’s most expensive acquisition ever at the time. With carbonated drink sales on the decline, the beverage giant sought to diversify its revenue into the rapidly growing functional beverage market, which already accounted for about half of non-alcoholic beverage revenue […]
THC BioMed Reports Growing Revenue & Profitability
Cannabis investors had already been shifting from “unproven potential” to “profitability” over the past several quarters prior to the global health crisis. With the COVID-19 outbreak, investors have fled previous investments to profitable companies that aren’t reliant on costly or dilutive funding to sustain their operations. THC BioMed Intl Ltd. (CSE: THC) recently recorded its […]
CFN Enterprises (OTCQB: CNFN) Names BlockChain Pioneer Tim Vasko to Board of Advisors
“We are pleased to welcome Tim Vasko, the Founder and CEO of BlockCerts Blockchain, to the Board of Advisors of CFN Enterprises. Tim is a cloud and blockchain pioneer, creating companies that have processed billions of transactions, proprietary tracking applications and a patent providing secure virtual spaces,” said Brian Ross, Chairman and CEO of CFN Enterprises Inc.
The cannabis industry has experienced record sales throughout the COVID-19 outbreak, making it one of the few attractive corners of the market. While there are many different cannabis companies and products, LucidMood™ has become one of the most popular brands in the space with its mood-based product selection. Let’s take a look at how LucidMood™ […]
Champignon Receives DTC Eligibility
VANCOUVER, British Columbia, April 17, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTC: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce its common […]
Calgary, Alberta, April 16, 2020 – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), is pleased to announce that it has entered into a strategic Agreement in Principle with Alberta BioPhotonics Inc. (“ABP”) and Albany MedicalCollege (“AMC”) to form FluroTest LLC (“FluroTest”). The CompleTestTM adaptation is expected to take approximately three months with trials planned shortly thereafter. […]
The COVID-19 outbreak has severely disrupted the economy and could push the world into the sharpest economic contraction since the Great Depression in the 1930s. While the cannabis industry has been largely spared thus far, companies have been forced to adopt new business models and strategies to succeed in the ‘new normal’. Innoviom, a […]
The COVID-19 outbreak has majorly disrupted nearly every business — including the nascent cannabis industry. While cannabis sales have spiked due to greater demand, businesses face unique risks as they adapt to rapidly changing consumer behaviors. More consumers are shopping online and ordering for delivery, while brick-and-mortar locations are looking for ways to reduce risk […]
THC.CSETHCBF – OTCTFHC.F VANCOUVER, April 7, 2020 /PRNewswire/ – THC BioMed Intl Ltd. (“THC BioMed” or the “Company“) is pleased to announce that its new cannabis beverage, THC Kiss, will be available for sale to Medical Patients this week. THC BioMed expects to begin its rollout of THC Kiss to the recreational market over the next few weeks. THC KISS is a brand […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Jushi and its trade main administration crew is constructing a built-in multi-state proprietor and operator of cannabis and hemp licenses throughout America. Jushi is concentrated on persevering with to construct a various multi-state portfolio of branded cannabis and hemp-derived property by means of opportunistic investments and by internally pursuing licenses in enticing jurisdictions. Jushi strives […]
Future Farm Technologies Inc. develops and acquires technologies that position it as a leader in the evolution of Controlled Environment Agriculture (CEA).
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
